Pharmaceutical Executive
Ilogistica has built a brand new warehouse facility with the latest technology to keep up with outsourcing demands
With the reform of CENABAST requiring the outsourcing of all its distribution activities, logistics providers are stepping up to meet the demand of pharmaceutical laboratories. Just outside of Santiago, iLogistica has built a brand new 8,000m2 storage warehouse with the latest technology for the most efficient distribution of pharmaceutical products. Having reconstructed almost from scratch after the earthquake in February of 2010, the company has refurbished itself to become the strategic partner for the industry. General manager, Raul Zamorano, explains his company's comparative advantage to serve the pharmaceutical industry: "being an entirely independent company that is not linked to any pharmaceutical laboratory, we can ensure the utmost confidentiality of our clients' data and product information. We also have no alliance with any of the players in the industry and this allows us to act freely always looking to serve our clients in the most efficient and effective way possible. In this sense we are positioned to become a trustworthy partner for any international company that wishes to distribute their products in Chile and who might have reservations about the safety of their company's data." The company has gone as far as developing a custom-made software platform that allows the greatest adaptability to the demands of its customers. "In order to provide the best traceability for our clients we have developed our own software platform that allows full customization to each one of our clients' needs," explains Zamorano.
Raul Zamorano, General Manager, iLogistica
iLogistica Santiago warehouse
Fake Weight Loss Drugs: Growing Threat to Consumer Health
October 25th 2024In this episode of the Pharmaceutical Executive podcast, UpScriptHealth's Peter Ax, Founder and CEO, and George Jones, Chief Operations Officer, discuss the issue of counterfeit weight loss drugs, the potential health risks associated with them, increasing access to legitimate weight loss medications and more.
The Transformative Role of Medical Information in Customer Engagement
October 3rd 2024Stacey Fung, Head of Global Medical Information at Gilead Lifesciences, delves into the evolving role of Medical Information (MI) in the pharmaceutical industry. Covering key topics like patient engagement through omnichannel strategies, combating misinformation, and leveraging AI to enhance medical inquiries, the conversation with Stacey highlights MI's critical role in ensuring patient safety and supporting drug development. She also shares her professional journey and tidbits for early career professionals on professional development.